Bio-C Sealer

Phase 3Small molecule

IInstitucion Universitaria Colegios de Colombia

Bio-C Sealer is one of 5 small molecule programs targeting Healing. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HealingActive, not recruiting

HealingPhase 3

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Healing

#DrugCompanyPhaseTrials

Carafate

AbbVie

Approved

2 2

Nexium

DDexcel Pharma Technologies Ltd.

Approved

1 3

Bio-C Sealer

IInstitucion Universitaria Colegios de Colombia

Phase 3

1 4

Psilocybin

COMPASS Pathways

Phase 1

1 5

Platelet Rich Fibrin

GGovernment Dental College and Research Institute, Bangalore

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Healing1 trial

Periapical Healing in Response to Endodontically Treated Teeth With Different Sealing Cement

Active, not recruiting·IInstitucion Universitaria Colegios de Colombia·Phase 4·NCT06482593·72 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Bio-C Sealer. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bio-C Sealer compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bio-C Sealer. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Institucion Universitaria Colegios de Colombia company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: IInstitucion Universitaria Colegios de Colombia

Bio-C Sealer

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Healing1 trial

References

Drug Info

Quick Facts

Related News